Ronald Evans

Ronald Evans

Director/Board Member at
The Salk Institute for Biological Studies
76 year
Health Technology
Commercial Services
Consumer Services

Profile

Ronald M.
Evans
is the founder of Ligand Pharmaceuticals, Inc. (1987), Syndax Pharmaceuticals, Inc. (2005), Synchronicity Pharma, Inc. (2008), Mitobridge, Inc. (2013), and Metacrine, Inc. (2014).
He is also the founder of Xenopharm, Inc., X-Ceptor Therapeutics, Inc., XTuit Pharmaceuticals, Inc. Dr. Evans's current jobs include Director & Professor at The Salk Institute for Biological Studies, Director at American Association for Cancer Research, Member at National Academy of Sciences, Member at American Academy of Arts & Sciences, and Member at National Academy of Medicine (United States).
Dr. Evans received his doctorate degree from the University of California, Los Angeles in 1974 and his undergraduate degree from the same university in 1970.

Ronald Evans active positions

CompaniesPositionStart
Director/Board Member -
Corporate Officer/Principal 25/01/2010
Corporate Officer/Principal 25/01/2010
Corporate Officer/Principal 25/01/2010
Director/Board Member -

Former positions of Ronald Evans

CompaniesPositionEnd
METACRINE, INC. Founder 23/03/2023
Founder -
Founder -
Founder -
░░░░░░░░░░ ░░░░ ░░░░░░░ -
See the detail of Ronald Evans's experience

Training of Ronald Evans

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

88

1st degree connections

14

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies14

Health Technology

Consumer Services

Health Technology

Commercial Services

Consumer Services

Commercial Services

Commercial Services

Commercial Services

Commercial Services

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!